Gross Margin
28.17%vs Specialty Chemicals peers Updated Sep 19, 2026Profit Margin
9.08%vs Specialty Chemicals peers Updated Sep 19, 2026Operating Margin
16.31%vs Specialty Chemicals peers Updated Sep 19, 2026Return on Assets (TTM)
2.99%vs Specialty Chemicals peers Updated Sep 19, 2026Return on Equity (TTM)
5.17%vs Specialty Chemicals peers Updated Sep 19, 2026Revenue (TTM)
618.83MCNY92.34M · vs all stocks (USD) Updated Sep 19, 2026Revenue per Share (TTM)
4.62CNYUpdated Sep 19, 2026Quarterly Revenue Growth
13.50%vs Specialty Chemicals peers Updated Sep 19, 2026Gross Profit (TTM)
166.81MCNY24.89M · vs all stocks (USD) Updated Sep 19, 2026EBITDA (TTM)
74.24MCNY11.08M · vs all stocks (USD) Updated Sep 19, 2026Net Income (TTM)
56.17MCNY8.38M · vs all stocks (USD) Updated Sep 19, 2026Quarterly Earnings Growth (YoY)
29.20%vs Specialty Chemicals peers Updated Sep 19, 2026Operating Cash Flow (TTM)
-9.23MCNY-1.38M · vs all stocks (USD) Updated Sep 19, 2026Trailing Annual Dividend Rate
0.0700CNYUpdated Sep 19, 2026Trailing Annual Dividend Yield
0.38%Updated Sep 19, 2026Payout Ratio
16.67%vs Specialty Chemicals peers Updated Sep 19, 2026Minority Interest (Equity)
1.75MCNYFY2025 · Dec 31, 2025Revenue
552.15MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
404.66MCNYFY2025 · Dec 31, 2025Gross Profit
147.49MCNYFY2025 · Dec 31, 2025Operating Income
55.63MCNY8.30M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
56.25MCNYFY2025 · Dec 31, 2025Income Tax Expense
7.21MCNYFY2025 · Dec 31, 2025Net Income
49.04MCNYFY2025 · Dec 31, 2025EBIT
60.31MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
94.69MCNYFY2025 · Dec 31, 2025Research & Development
20.20MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
26.79MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
9.38MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.06MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
134.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
134.05MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
49.04MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-778.31KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-53.94MCNYFY2025 · Dec 31, 2025Free Cash Flow
-127.78MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
411.64MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
49.04MCNYFY2025 · Dec 31, 2025Other Non-cash Items
7.42MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-80.86MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-29.54MCNYFY2025 · Dec 31, 2025Capital Expenditures
-73.84MCNYFY2025 · Dec 31, 2025Purchase of Investments
-22.50MCNYFY2025 · Dec 31, 2025Sale of Investments
22.62MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-73.72MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
109.78MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-80.21MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-15.86MCNYFY2025 · Dec 31, 2025Other Financing Charges
-255.78KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
13.45MCNYFY2025 · Dec 31, 2025